PSTPIP1
Proline-serine-threonine phosphatase-interacting protein 1
Also known as: CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PPIP1_HUMAN, PSTPIP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43586
- Gene
- PSTPIP1
- Ensembl
- ENSG00000140368
- Chromosome
- 15
- Canonical length
- 416 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a cytoskeletal protein that is highly expressed in hemopoietic tissues. This protein functions via its interaction with several different proteins involved in cytoskeletal organization and inflammatory processes. It binds to the cytoplasmic tail of CD2, an effector of T cell activation and adhesion, downregulating CD2-triggered adhesion. It binds PEST-type protein tyrosine phosphatases (PTP) and directs them to c-Abl kinase to mediate c-Abl dephosphorylation, thereby, regulating c-Abl activity. It also interacts with pyrin, which is found in association with the cytoskeleton in myeloid/monocytic cells and modulates immunoregulatory functions. Mutations in this gene are associated with PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) syndrome. It is hypothesized that the disease-causing mutations compromise physiologic signaling necessary for the maintenance of a proper inflammatory response. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
416 residues, UniProt reviewed canonical sequence.
>O43586|PSTPIP1
1 MMPQLQFKDA FWCRDFTAHT GYEVLLQRLL DGRKMCKDME ELLRQRAQAE ERYGKELVQI
61 ARKAGGQTEI NSLRASFDSL KQQMENVGSS HIQLALTLRE ELRSLEEFRE RQKEQRKKYE
121 AVMDRVQKSK LSLYKKAMES KKTYEQKCRD ADDAEQAFER ISANGHQKQV EKSQNKARQC
181 KDSATEAERV YRQSIAQLEK VRAEWEQEHR TTCEAFQLQE FDRLTILRNA LWVHSNQLSM
241 QCVKDDELYE EVRLTLEGCS IDADIDSFIQ AKSTGTEPPA PVPYQNYYDR EVTPLTSSPG
301 IQPSCGMIKR FSGLLHGSPK TTSLAASAAS TETLTPTPER NEGVYTAIAV QEIQGNPASP
361 AQEYRALYDY TAQNPDELDL SAGDILEVIL EGEDGWWTVE RNGQRGFVPG SYLEKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSTPIP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 55 nTPM
- spleen: 30 nTPM
- lymph node: 15 nTPM
- appendix: 14 nTPM
- lung: 9.6 nTPM
- small intestine: 8.3 nTPM
Single-cell type
- oocytes: 520 nCPM
- neutrophils: 130 nCPM
- neutrophil progenitors: 129 nCPM
- monocytes: 77 nCPM
- monocyte progenitors: 70 nCPM
- hofbauer cells: 66 nCPM
Immune cell
- neutrophil: 88 nTPM
- classical monocyte: 74 nTPM
- eosinophil: 74 nTPM
- myeloid DC: 61 nTPM
- total PBMC: 44 nTPM
- NK-cell: 42 nTPM
Brain region
- thalamus: 4.2 nTPM
- choroid plexus: 3.8 nTPM
- medulla oblongata: 3.2 nTPM
- midbrain: 3 nTPM
- spinal cord: 2.9 nTPM
- pons: 2.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PSTPIP1.
Disease | AllUniProt
Conditions PSTPIP1 is implicated in, by any mechanism.
- Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) MIM:604416
- Autoinflammatory syndrome with cytopenia, hyperzincemia, and hypercalprotectinemia (AICZC) MIM:601979
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 832 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome
- Hyperzincemia and hypercalprotectinemia
- PSTPIP1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSTPIP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSTPIP1 as an antibody target. Whether an autoantibody or antibody against PSTPIP1 could matter depends on whether native PSTPIP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSTPIP1 is annotated at the cell surface, where native PSTPIP1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PSTPIP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...